Swansea chosen to host UK Diabetes Centre of Excellence.

22 May 2018

Sanofi BalconyPS.jpg

Picture:  At the launch of the Sanofi UK Diabetes Centre of Excellence, (left to right), Anne Scoggins, Diabetes Portfolio Lead, Senior Clinical project leader Sanofi UK; Hubert Bland, Country Medical Chair and Medical Head, Sanofi UK; Sarah Gibbs, Diabetes Research Unit Cymru Public Reference Panel member; Professor Steve Bain, ABMU and Swansea University; Olatunde Falode, General Manager Diabetes and Cardiovascular, Sanofi UK; Kathie Wareham, JCRF, Swansea University; Professor Keith Lloyd, Dean of the Medical School; Henrik Schou, Head of Diabetes Franchise, Medical Affairs, Sanofi UK; Professor Andrew Davies, Chairman, ABMU.

The Joint Clinical Research Facility (JCRF), in collaboration with the Diabetes Research Unit Cymru, has been chosen by Sanofi to become part of its Global Investigator Network as a new national centre of excellence. The JCRF is a joint enterprise between Abertawe Bro Morgannwg University Health Board (ABMU) and Swansea University Medical School. The Diabetes Research Unit Cymru is funded by Welsh Government via Health and Care Research Wales.

Having worked closely on several clinical studies for Sanofi, the JCRF was chosen to join the company’s Global Investigator Network after repeatedly demonstrating the ability to deliver a first class service, meeting timelines from feasibility through to study completion.

Professor Steve Bain, ABMU Assistant Medical Director for Research and Development and Clinical Lead for the Diabetes Research Unit Cymru, said:

“There are more than 190,000 people in Wales living with diabetes. This is 7.3% of the population aged 17 years and over – the highest prevalence in the UK. Research into new treatments is vital and opportunities for patients in the ABMU catchment to take part in clinical trials of new medicines and devices is to be welcomed.”

“The JCRF has an excellent track record for rapid recruitment and patient retention which is vital to the successful delivery of clinical trials. The vast experience of investigators in the Diabetes Research Unit Cymru, along with their accredited laboratory and public reference panel, enables a comprehensive service across diabetes research.”

“We look forward to working on the exciting pipeline of medicines in development with Sanofi.”

“The goal of this partnership is to apply the JCRF’s diabetes research expertise to help accelerate the conduct of Sanofi’s clinical trials,” said Victoria DiBiaso, global head of Clinical Operations Strategy & Collaboration at Sanofi. “Fostering relationships with key research sites, combined with our global and U.K clinical study unit’s operational experience in each phase of trial development, helps us advance medically meaningful studies for the benefit of patients.”


Professor Jon Bisson, Director of Health and Care Research Wales

Welsh Government recognises industry’s part in global research collaborations are critical to address unmet clinical needs and further support economic growth in Wales, and we welcome this strategic partnership with Sanofi.  The Joint Clinical Research Facility at Abertawe Bro Morgannwg University Health Board plays an important role in increasing research opportunities for patients to join national and international high quality research studies within their locality.